Larvol Delta - Asher-Bio-Announces-New-Preclinical-Data-Demonstrating-BestinClass-Potential-of-AB248-Its-Lead-CisTargeted-Il2-Immunotherapy

AB248 - Asher Biotherap

https://www.businesswire.com/news/home/20211112005328/en/Asher-Bio-Announces-New-Preclinical-Data-Demonstrating-Best-in-Class-Potential-of-AB248-Its-Lead-Cis-Targeted-Il-2-Immunotherapy

Nov 12, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next